Press release
U.S. Pharmacogenomics Market Size (USD 5,676.1 Million by 2031) Achieves Record-breaking Growth in Meeting Healthcare Requirements
U.S. Pharmacogenomics Market
The U.S. pharmacogenomics market is experiencing significant growth due to several driving factors. Firstly, advancements in genomic research and technology have enabled personalized medicine approaches, which utilize genetic information to determine the most effective treatments for individuals. This has increased the demand for pharmacogenomics testing and analysis. Secondly, growing awareness among healthcare professionals and patients about the potential benefits of pharmacogenomics in optimizing drug therapy is driving adoption. Additionally, the rising prevalence of chronic diseases and the need for more targeted therapies further fuel the market growth. Moreover, supportive government initiatives, increasing investment in research and development, and collaborations between pharmaceutical companies and research institutions are contributing to the market expansion.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/47832
Top US Pharmacogenomics Companies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• F. Hoffmann-La Roche Ltd.
• QIAGEN
• Agilent Technologies, Inc.
• Eurofins Scientific
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Myriad Genetics, Inc.
US Pharmacogenomics Market Segmentation: -
The pharmacogenomics market can be segmented based on technology, application, end-user, and region. Here's a brief overview:
By Technology
• Next Generation Sequencing
• Polymerase Chain Reaction
• Gel Electrophoresis
• Mass Spectrometry
• Microarray
• Others
By Application
• Cardiovascular Diseases
• Infectious Diseases
• Oncology
• Neurological Diseases
• Psychiatry
• Others
By End User
• Hospitals & Clinics
• Research Institutions
• Academic Institutes
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/47832
Key Findings Of Study
• By technology, the polymerase chain reaction segment was the highest contributor to the U.S. Pharmacogenomics Market in 2021.
• Depending on application, the oncology segment dominated the U.S. Pharmacogenomics Market in 2021, and is expected to continue this trend during the forecast period.
• Depending on end user, the hospitals & clinic segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
By Region Outlook
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Pharmacogenomics Market Size (USD 5,676.1 Million by 2031) Achieves Record-breaking Growth in Meeting Healthcare Requirements here
News-ID: 3980721 • Views: …
More Releases from Allied Market Research (AMR)
Pest Control Market 2025-2034: Growth Opportunities & Competitive Landscape
Allied Market Research (AMR) recently published an in-depth report on the global pest control market, projecting the industry to reach $42.5 billion by 2032, growing at a CAGR of 5.7% from 2023 to 2032. The market was valued at $24.6 billion in 2022, reflecting strong momentum fueled by rising demand across residential, commercial, and industrial sectors.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/2328
Evolving Market Dynamics:
- The report provides a comprehensive assessment…
Smart Polymers Market Emerging Demand, Business Profit Analysis, Sales Revenue a …
According to a recent report by Allied Market Research (AMR), the global smart polymers market is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2033, reaching a valuation of $20.4 billion by 2033, up from $10.3 billion in 2023. The report delivers an in-depth assessment of market dynamics, including emerging trends, investment opportunities, competitive landscapes, and key growth drivers shaping the industry's future.
Download…
Graphite Market 2026 | In-Depth Players Analysis, Revenue, Growth and Regional O …
According to a report published by Allied Market Research, titled "Graphite Market by Type (Natural Graphite and Synthetic Graphite), and Application (Lubrication, Refractories, Foundry, Battery Production, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033", the global graphite market was valued at $8.4 billion in 2023 and is projected to reach $13.2 billion by 2033, growing at a CAGR of 4.8% during the forecast period.
Download Sample Pages of Research Overview:…
Base Oil Market Report: Market Size, Segmentation & Strategic Outlook (2026-2033 …
The global base oil market report published by Allied Market Research (AMR) delivers a comprehensive assessment of the industry's current landscape and future outlook. The study provides in-depth quantitative and qualitative insights for the forecast period from 2025 to 2033, enabling stakeholders to gain a clear understanding of prevailing market conditions. It highlights the key growth drivers, emerging trends, restraints, and opportunities shaping the industry's evolution.
According to the report, the…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
